Case Report
Medullary thyroid carcinoma and 2q37 deletion in a patient with nevoid basal cell carcinoma syndrome: Clinical description and genetic analysis
Article first published online: 9 FEB 2012
DOI: 10.1002/hed.22000
Copyright © 2012 Wiley Periodicals, Inc.
Additional Information
How to Cite
Coca–Pelaz, A., Llorente–Pendás, J. L., García–Martínez, J., Vivanco–Allende, B., Balbín, M., Suárez, C., Hermsen, M. (2012), Medullary thyroid carcinoma and 2q37 deletion in a patient with nevoid basal cell carcinoma syndrome: Clinical description and genetic analysis. Head Neck. doi: 10.1002/hed.22000
Publication History
- Article first published online: 9 FEB 2012
- Manuscript Accepted: 22 SEP 2011
Funded by
- EMER07-048 of Fondos de Investigación Sanitaria (FIS), RD06/0020/0034 of Red Temática de Investigación Cooperativa en Cáncer (RTICC), Spain, and the FEDER Funding Program from the European Union
- Abstract
- Article
- References
- Cited By
Keywords:
- Gorlin–Goltz syndrome;
- nevoid basal cell carcinoma syndrome;
- medullary thyroid carcinoma;
- genetic analysis;
- 2q37 deletion
Abstract
Background
Nevoid basal cell carcinoma syndrome (NBCCS) is a rare, inheritable, multisystem disorder characterized by numerous basal cell carcinomas (BCCs), maxillary keratocyst, and musculoskeletal malformations. Occasionally, it is associated with malignancies like rhabdomyoma, melanoma, and sinonasal undifferentiated carcinoma, to name a few.
Methods
A patient presented with NBCCS with a medullary thyroid carcinoma. Clinical, surgical details, and germline genetic analysis are herein described.
Results
A 32-year-old woman was referred to our department with suspicion of medullary thyroid carcinoma, which was confirmed by histopathological examination. The patient was diagnosed as also having NBCCS. Germline mutation analysis indicated wild-type genes PTCH1 and RET. DNA copy number analysis by high resolution microarray comparative genomic hybridization (CGH) revealed a small interstitial loss at chromosomal band 2q37.3.
Conclusion
To our knowledge, this is the first described patient with NBCCS carrying a medullary thyroid carcinoma and a 2q37 deletion, which confirms that this syndrome can be associated with many different malignancies. © 2012 Wiley Periodicals, Inc. Head Neck, 2012

1097-0347/asset/HED_left.gif?v=1&s=885630f8ce9449c0cfd5b8f9b80545a21e7ac7ef)
1097-0347/asset/HED_right.gif?v=1&s=60d05f6fe75aefef929d29948b1fec4cb984fe91)
